There is great potential for deploying wearables in clinical trials to gain better metrics on patient behaviour and their response to the medication

Wearables are making a big impact on the consumer scene, with the Apple Watch setting the trend for general-purpose devices and FitBit well-established in wellness and fitness related applications.

With general-purpose consumer devices available widely and at relatively low cost, is it worth continuing to develop the existing ranges of specialist medical grade devices for this market, or could we make better use of the technology that already exists by re-purposing it with custom apps? How will such technology drive future clinical trial strategies in the pharma industry?

Join Richard Lingard (Dotmatics), Matt Jones (Tessella), Marie McCarthy (ICON), and Christian Gossens (Roche) for this Pistoia Alliance Debates webinar.